Literature DB >> 28118041

Return of Research Results in the Saudi Biobank: An Exploratory Survey.

Ghiath Alahmad1, Kris Dierickx2.   

Abstract

BACKGROUND AND AIMS: There are many research biobanks in the world, including a small number in the Middle East. The Saudi biobank, one of the newly established biobanks, has just started to collect data and samples in 2016.
METHODS: A survey was conducted to assess the opinions of stakeholders regarding the return of individual research results. A total of 180 adults from three different groups (researchers, physicians, and laypeople) participated in this cross-sectional study.
RESULTS: There was strong agreement among all respondents that the biobank has the duty and donors have the right to be provided with important results that may have direct or indirect benefits. Moreover, there was strong support for the view that donors have the right to refuse to receive any research results.
CONCLUSIONS: These results are compatible with many other studies and are in line with the governance of the Saudi biobank.

Keywords:  Saudi; biobank; return of results

Mesh:

Year:  2017        PMID: 28118041     DOI: 10.1089/gtmb.2016.0396

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  3 in total

1.  Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues.

Authors:  Ahmed Samir Abdelhafiz; Eman A Sultan; Hany H Ziady; Douaa M Sayed; Walaa A Khairy
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

2.  What Egyptians think. Knowledge, attitude, and opinions of Egyptian patients towards biobanking issues.

Authors:  Ahmed S Abdelhafiz; Eman A Sultan; Hany H Ziady; Ebtesam Ahmed; Walaa A Khairy; Douaa M Sayed; Rana Zaki; Merhan A Fouda; Rania M Labib
Journal:  BMC Med Ethics       Date:  2019-08-09       Impact factor: 2.652

3.  Sharing, reuse, and storage of biosamples among biomedical researchers in Jordan: Practice and concerns.

Authors:  Almuthanna K Alkaraki; Omar F Khabour; Karem H Alzoubi; Lina M K Al-Ebbini; Zaid Altaany
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.